Examples of using Extavia in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
However, the long-term impact of early treatment with Extavia is unknown even in these high risk subgroups as this study was mainly designed to assess the time to CDMS rather than the long-term evolution of the disease.
In patients with relapsing remitting MS, Extavia was more effective than placebo in reducing the number of annual relapses:
Secondary progressive multiple sclerosis(SP-MS) Two controlled clinical trials with Extavia involving a total of 1,657 patients with secondary progressive multiple sclerosis(baseline EDSS 3 to 6.5, i. e. patients were able to walk) were performed.
Single clinical event suggestive of multiple sclerosis One controlled clinical trial with Extavia was performed in patients with a single clinical event and Magnetic Resonance Imaging(MRI) features suggestive of
RR-MS, SP-MS and single clinical event suggestive of MS Extavia was effective in all multiple sclerosis studies to reduce disease activity(acute inflammation in the central nervous system
If you forget to use Extavia If you have forgotten to give yourself an injection at the right time do it as soon as you remember
There is no evidence of an effect of Extavia on the duration of relapses or on symptoms in between relapses,
Extavia should be administered with caution to patients with a history of seizures,
List 1: Very common side effects which have occurred in clinical trials with Extavia(may affect more than 1 in 10 people)
detected in the cap, the safe use of Extavia pre-filled syringe in latex-sensitive individuals has not been studied
After the solvent in the syringe has been completely injected into the Extavia vial, hold the vial between your thumb, forefinger and middle finger with the needle and syringe resting against your hand and swirl the vial gently to completely dissolve the powder of Extavia.
Caution should be exercised when Extavia is administered in combination with medicinal products that have a narrow therapeutic index
Extavia prolonged the time to CDMS by 363 days, from 255 days in the placebo group to 618 days in the Extavia group based on the 25th percentiles.
Preparing the injection Before injection, the Extavia solution has to be prepared from a vial of Extavia powder
During the post-marketing period very rare reports have been received of temporary worsening of cardiac status at the start of Extavia therapy in patients with pre-existing significant cardiac disease.
Therapy with Extavia was well accepted in the study of patients with a single clinical event as indicated by a high rate of trial completion 92.8% in the Extavia group.
During the post-marketing period very rare reports have been received of worsening of cardiac status in patients with pre-existing significant cardiac disease temporarily associated with the initiation of Extavia therapy.
Patients with single lesions may continue on Extavia provided the necrosis is not too extensive, as some patients have experienced healing of injection site necrosis whilst on Extavia.
rate before treatment started, the risk of a severe relapse following discontinuation of Extavia in the event of pregnancy should be weighed against a possible increased risk of spontaneous abortion.
solution for injection) into the Extavia vial.